首页> 外文OA文献 >Viral Safety of Plasma-derived Blood Products. I. Efficiency of Virus Inactivation/Elimination during Manufacturing Process of Monoclonal Antibody-purified Freeze-Dried Coagulation Factor VIII Concentrate(CROSS EIGHT M).

【2h】

Viral Safety of Plasma-derived Blood Products. I. Efficiency of Virus Inactivation/Elimination during Manufacturing Process of Monoclonal Antibody-purified Freeze-Dried Coagulation Factor VIII Concentrate(CROSS EIGHT M).

机译：等离子体衍生血液产品的病毒安全性。 I.在单克隆抗体纯化的冷冻干燥凝固因子VIII浓缩物的制造过程中病毒失活/消除的效率（十字八m）。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Takashi Murozuka; Hironari Izumi; Katsushi Murai; Sachiko Shirakawa; Yoshio Takeda; Hiroyuki Emura; Akemi Wakisaka; Shuzo Matsumoto; Nobuhiro Fujii;
展开▼
作者单位

展开▼
年度 1999
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Pasteurized, monoclonal antibody factor VIII concentrate: establishing a new standard for purity and viral safety of plasma-derived concentrates. [J] . Goldsmith JC Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis . 2000,第2期

机译：巴氏灭菌，单克隆抗体因子VIII浓缩物：建立血浆衍生浓缩物的纯度和病毒安全性新标准。
2. Soluble interleukin 2 receptor and soluble CD8 levels in previously treated human immunodeficiency virus-negative hemophiliacs multiply transfused with a monoclonal antibody-purified factor VIII concentrate. [J] . Smid WM, Martens A, van der Meer J, Transfusion: The Journal of the American Association of Blood Banks . 1997,第1期

机译：先前治疗过的人类免疫缺陷病毒阴性血友病患者中的可溶性白细胞介素2受体和可溶性CD8水平用单克隆抗体纯化的VIII因子浓缩液多次输血。
3. A solvent/detergent-treated and 15-nm filtered factor VIII: a new safety standard for plasma-derived coagulation factor concentrates. [J] . Chtourou S, Porte P, Nogre M, Vox Sanguinis: International Journal of Blood Transfusion and Immunohaematology . 2007,第4期

机译：溶剂/去污剂处理和15纳米过滤因子VIII：血浆衍生凝血因子浓缩物的新安全标准。
4. Viral Safety of Plasma-derived Blood Products. II. Effect of Virus Elimination by Nanofiltration Using PLANOVA35N on Monoclonalpurified Freeze-Dried Coagulation Factor VIII Concentrate(CROSS EIGHT M) and Intramascular Human Immunoglobulin (Anti-HBs Human immune Globulin "Nisseki" and Human Immune Globulin "Nisseki"). [O] . Hironari Izumi, Katsushi Murai, Sachiko Shirakawa, 1999

机译：等离子体衍生血液产品的病毒安全性。 II。纳米过滤在单克隆氢化冷冻干燥凝血因子VIII浓缩物（十字八米）和颅内人免疫球蛋白（抗HBs人免疫球蛋白“NisseSeki”和人免疫球蛋白“NisseSeki”）的影响。

Viral Safety of Plasma-derived Blood Products. I. Efficiency of Virus Inactivation/Elimination during Manufacturing Process of Monoclonal Antibody-purified Freeze-Dried Coagulation Factor VIII Concentrate(CROSS EIGHT M).

著录项

引文网络

相似文献

相关主题

期刊订阅